Copper dependency in leukemia metabolism
Leukemia cells have a unique copper dependency that healthy cells don't share, opening a new avenue for selective cancer-cell killing.
Copper-handling proteins and transport systems represent a metabolic dependency unique to leukemia cells, positioning copper chelation and redirection strategies as exploitable therapeutic vulnerabilities. This record was retained from the prior triage attempt for PubMed pipeline handoff.
What the study was
- Study design
- perspective
- Category
- Other
- Maturity
- Validated
- Journal
- Nat Cancer
Why it surfaced
Nature Cancer perspective from a leading leukemia center signals an emerging therapeutic paradigm; copper-targeting drugs (disulfiram, copper chelators) are in clinical investigation; title-only metadata limits scoring despite strong journal/institution signal.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.